Loading…

The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales

Saved in:

Bibliographic Details
Published in:	Rheumatology (Oxford, England) England), 2017-06, Vol.56 (6), p.1041-1043
Main Authors:	McCarthy, Eoghan M, Sutton, Emily, Nesbit, Stephanie, Parker, Ben, Jayne, David, Griffiths, Bridget, Isenberg, David A, Rahman, Anisur, Gordon, Caroline, D'Cruz, David P, Rhodes, Benjamin, Lanyon, Peter, Vital, Edward M, Yee, Chee-Seng, Edwards, Christopher J, Teh, Lee-Suan, Akil, Mohammed, McHugh, Neil J, Zoma, Asad, Bruce, Ian N
Format:	Article
Language:	English
Subjects:	Antibodies, Monoclonal, Humanized - therapeutic use England Humans Immunosuppressive Agents - therapeutic use Letters to the Editor Lupus Erythematosus, Systemic - drug therapy Practice Guidelines as Topic Rituximab - therapeutic use Wales
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!